{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -2.36, "sharesOutstanding": 90200000, "bookValue": 5.297, "fiftyDayAverage": 34.788, "fiftyDayAverageChange": -1.0379982, "fiftyDayAverageChangePercent": -0.029837824, "twoHundredDayAverage": 36.713, "twoHundredDayAverageChange": -2.9630013, "twoHundredDayAverageChangePercent": -0.08070714, "marketCap": 3044250112, "priceToBook": 6.371531, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "currency": "TWD", "financialCurrency": "TWD", "regularMarketOpen": 34.1, "averageDailyVolume3Month": 127862, "averageDailyVolume10Day": 68412, "fiftyTwoWeekLowChange": 5.8500004, "fiftyTwoWeekLowChangePercent": 0.20967744, "fiftyTwoWeekRange": "27.9 - 53.1", "fiftyTwoWeekHighChange": -19.349998, "fiftyTwoWeekHighChangePercent": -0.36440676, "fiftyTwoWeekLow": 27.9, "fiftyTwoWeekHigh": 53.1, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1498006800000, "priceHint": 2, "marketState": "POSTPOST", "regularMarketChange": -0.40000153, "regularMarketTime": 1684128594, "regularMarketDayHigh": 34.1, "regularMarketDayRange": "33.15 - 34.1", "regularMarketDayLow": 33.15, "regularMarketVolume": 61449, "regularMarketPreviousClose": 34.15, "bid": 33.15, "ask": 33.75, "bidSize": 0, "askSize": 0, "fullExchangeName": "Taipei Exchange", "regularMarketChangePercent": -1.1713074, "regularMarketPrice": 33.75, "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "exchange": "TWO", "shortName": "TaiRx", "longName": "TaiRx, Inc.", "messageBoardId": "finmb_315439521", "market": "tw_market", "symbol": "6580.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 66, San-Chung Road", "address2": "6th Floor-1 Nankang Business Park", "city": "Taipei City", "zip": "11502", "country": "Taiwan", "phone": "886 2 2653 5007", "fax": "886 2 2653 5008", "website": "https://www.trx.com.tw", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "TaiRx, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases. The company's products under development include CVM-1118, an oral anti-cancer drug that is Phase II clinical trial; and Rexis, an add-on injection therapy that is in Phase III clinical trials to treat patients with sepsis. Its pre-clinical products comprise TRX-711 that is used to treat secondary hyperparathyroidism; TRX-920, an oral delivery formulation; and TRX-105, a molecule developed for treating and alleviating symptoms of various colitis. The company also offers Zelnite, a drug that helps in patient's blood Se level and immune system; and focuses on development of the nodal diagnostic devices and anti-body drugs. TaiRx, Inc. was founded in 2011 and is based in Taipei City, Taiwan.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Chien  Du-Shieng Ph.D.", "title": "Co-Founder, Pres, CEO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jackson  Huang M.A.", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yi-Wen  Chu Ph.D.", "title": "Sr. VP & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}